Skip to content
Homepage
Clinic directory

Clinics in South Miami, Florida

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

South Miami, FL

Stem Cell Therapy clinics in South Miami

South Miami supports a regenerative medicine market shaped by both private clinics and regional academic medicine. Local referral networks run through Baptist Health South Miami Hospital and nearby UM Health, and stem cell practice in the area spans South Miami, Coral Gables border, and Pinecrest. Patient demand splits across three buckets: orthopedic injections for active adults and aging athletes, neurological and autoimmune protocols marketed to longevity-focused patients, and IV-based allogeneic products offered by private wellness clinics. The FDA classifies most stem cell injections for orthopedic, neurological, or longevity use as investigational biologics under 21 CFR Part 1271, meaning they require either a Biologics License or an active Investigational New Drug authorization. Autologous bone marrow and adipose products may qualify as Section 361 when minimally manipulated and used for homologous function. Florida has seen active FDA enforcement, most notably the 2019 permanent injunction against US Stem Cell Clinic in Sunrise after patients were blinded by adipose stem cell injections into their eyes. The Florida Board of Medicine licenses physicians, and the Department of Health Division of Medical Quality Assurance investigates clinics. There is no Florida-specific stem cell disclosure law, so federal rules under 21 CFR Part 1271 apply. The 6 South Miami clinics listed below have been reviewed against our vetting criteria, including federal NPI lookup, OIG exclusion screening, and Florida Board of Medicine licensure checks.

5 Clinics

Miami Stem Cell

South Miami, FL

Miami Stem Cell, a regenerative-medicine clinic in South Miami, offers stem-cell therapy using umbilical-cord and autologous sources, alongside exosome and growth-factor injections. The practice also…

  • PRP Therapy
  • IV Therapy
  • Arthritis Treatment
  • Peptide Therapy
  • Erectile Dysfunction (ED) Treatment
 MD on staff

South Miami Walk In Orthopedics & Sports Medicine

South Miami, FL

South Miami Walk-In Orthopedics & Sports Medicine, a regenerative medicine clinic in South Miami, specializes in orthobiologic and cell-based therapies for musculoskeletal injuries and degenerative c…

  • PRP Therapy
  • Arthritis Treatment
  • Red Light Therapy
  • Stem Cell Therapy
MD on staff

BetterStem

South Miami, FL

BetterStem, a regenerative medicine clinic in South Miami, specializes in stem-cell therapy for children with autism. The clinic offers mesenchymal stem-cell protocols derived from umbilical cord and…

  • Multiple Sclerosis (MS) Treatment
  • Arthritis Treatment
  • Erectile Dysfunction (ED) Treatment
  • Stem Cell Therapy
 MD on staff

USA Stem Cell

South Miami, FL

USA Stem Cell, a regenerative medicine clinic in South Miami, offers stem-cell therapy, platelet-rich plasma injections, and exosome treatment for patients seeking alternatives to conventional pain m…

  • PRP Therapy
  • Arthritis Treatment
  • Migraine Treatment
  • Stem Cell Therapy
 MD on staff

MD Ageless Solutions

South Miami, FL

MD Ageless Solutions, a regenerative medicine clinic in Miami, offers hormone replacement therapy including bioidentical pellet implantation, alongside stem-cell therapy, platelet-rich plasma injecti…

  • Stem Cell Therapy
  • NAD IV Therapy
  • Vitamin IV Therapy
  • PRP Therapy
  • IV Therapy
15 30 50 results per page

Regulatory context

A note on Florida's stem cell therapy rules.

Florida cellular therapy providers are governed by 21 CFR Part 1271. Section 361 applies to minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 applies to products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND or BLA. Most stem cell, stromal vascular fraction, exosome, umbilical cord blood derived, and culture-expanded mesenchymal cell therapies marketed in Florida for orthopedic, neurologic, autoimmune, and longevity indications fall under Section 351 and lack FDA approval. Florida is a high-volume market, which has translated into elevated federal scrutiny.

  • Florida Medical Practice Act, Florida Statutes Chapter 458 and Chapter 459
    Establishes MD and DO licensure and disciplinary authority through the Florida Board of Medicine and Board of Osteopathic Medicine.
  • Florida Pharmacy Act, Florida Statutes Chapter 465
    Regulates compounding pharmacies in Florida and aligns with federal 503A and 503B standards relevant to biologic preparation.
  • Florida Stem Cell Therapy Disclosure Rules, Florida Administrative Code Rule 64B8-9.0091 and 64B15-14.0091
    Require physicians offering non-FDA-approved stem cell therapies to provide written disclosure of regulatory status to patients.

Florida has been a primary target of FDA enforcement. In US v US Stem Cell Inc (2019), a federal court in Florida granted a permanent injunction against a Sunrise-based clinic for marketing unapproved stem cell products derived from adipose tissue. The Eleventh Circuit upheld the injunction in 2021. The FDA has issued multiple warning letters to Florida clinics offering exosome and umbilical cord-derived therapies. The Florida Department of Health and the Boards of Medicine and Osteopathic Medicine have disciplined physicians for unprofessional conduct tied to misleading regenerative medicine marketing. The Florida Attorney General has pursued deceptive trade practice claims under FDUTPA against stem cell clinics.

Sources: fda.gov · flsenate.gov · flboardofmedicine.gov

Stem Cell Therapy in South Miami, answered.

Most stem cell therapies at private South Miami clinics are not FDA-approved. The FDA has approved certain hematopoietic stem cell products for blood and immune disorders, but stem cell injections for orthopedic, neurological, or longevity use are generally investigational. They require a Biologics License or an active Investigational New Drug authorization, or they must qualify as Section 361 minimally manipulated and homologous-use products under 21 CFR Part 1271. Florida has seen active FDA enforcement, most notably the 2019 permanent injunction against US Stem Cell Clinic in Sunrise after patients were blinded by adipose stem cell injections into their eyes.

South Miami sits in the premium metro tier. Single-joint autologous bone marrow or adipose injections typically run $5,000 to $15,000 per session. Systemic IV protocols using allogeneic umbilical cord or Wharton's jelly products range $10,000 to $25,000, and full multi-session protocols can reach $20,000 to $50,000. Exosome add-ons range $4,000 to $8,000. Insurance rarely covers these treatments because the FDA classifies most protocols as investigational.

Autologous stem cells come from your own body, usually harvested from bone marrow aspirate or adipose tissue and reinjected the same day. When minimally manipulated and used for homologous function, they often fall under FDA Section 361, which does not require pre-market approval. Allogeneic stem cells come from a donor source, most commonly umbilical cord blood or Wharton's jelly, and are generally classified as Section 351 biologics that require an active Investigational New Drug authorization. South Miami clinic offerings span both categories, so ask which classification applies before treatment.

Yes. Research programs at Baptist Health South Miami Hospital and nearby UM Health periodically run FDA-authorized stem cell trials across orthopedics, neurology, cardiology, and oncology. Search clinicaltrials.gov and filter by South Miami or the broader metro to see active recruiting studies. Trial participation is typically low-cost or free compared to commercial protocols and includes structured follow-up with imaging and lab monitoring.

Verify physician licensure through the Florida Board of Medicine and confirm the clinic's NPI number through the NPPES registry. Check the FDA warning letter database for the clinic name and the HHS Office of Inspector General exclusion list. Ask whether the treatment is Section 361 or Section 351, whether the clinic operates under an Investigational New Drug authorization for allogeneic or expanded products, and whether adverse events are tracked. Ask specifically about compliance with federal 21 CFR 1271.

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology